Search

everythinglearnresearchcommunity

for

Search:↓

Skin organoids from stem cells could better mimic real skin but face challenges.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Entrepreneurial companies are key to advancing dermatology treatments and patient care.

Standardizing and engineering organoids can improve their use in medicine and drug testing.

Advanced human skin models improve drug development and could replace animal testing.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

The C3H/HeJ mouse model is useful for studying and testing treatments for alopecia areata.

3D bioprinting is useful for making tissues, testing drugs, and delivering drugs, but needs better materials, resolution, and scalability.

The platform effectively grows lung cancer cell spheroids for drug testing.

Wait 4-5 weeks after drug use before hair testing and cut hair into three segments to confirm single drug exposure.

Hair testing is crucial for forensic science and public health.

Microneedles with green tea polyphenols improve diabetic wound healing.

Human hair follicle organ culture is a useful model for hair research with potential for studying hair biology and testing treatments.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

New technologies replicate human skin for testing without animals.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Microneedles are becoming essential tools in medicine for sensing, drug delivery, and communication.

Animal models help study psoriasis but have limitations and don't fully mimic the human disease.

Humanized animal models using human stem cells can improve disease research and drug testing.

The document concludes that while finding animal models for the skin disease Hidradenitis suppurativa is challenging, certain mouse mutations may provide useful insights for research and drug testing.

Bioprinting is improving skin models for better testing of skin diseases without using animals.

Hair analysis can detect drug use but is costly and interpretation is complex.

Organoid technology is improving personalized medicine by better predicting drug responses and treatments.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Precise cell manipulation technologies are advancing but still face challenges in improving accuracy for medical use.

Organoids help study and treat genetic diseases, offering personalized medicine and therapy testing.

In vitro skin models are improving but still need more innovation to fully replicate human skin.

iPSCs are promising for studying and treating COVID-19.

Skin-on-a-chip devices better mimic human skin for research.